Howard SC, McCormick J, Pui CH, et al: Preventing and managing toxicities of high-dose methotrexate. Oncologist 21 (12): 1471-1482, 2016.
Goldin A, Venditti JM, Kline I, et al: Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor. Nature 212 (5070) : 1548- 1550, 1966.
Jaffe N: Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30 (6): 1627-1631, 1972.
Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43 (6): 2163-2177, 1979.
Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49 (6) :1221-1230, 1982.